Moderna (MRNA) Q4 2022 Earning Report Analysis
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…